Singapore Med J 2014; 55(8): e136-e138; http://dx.doi.org/10.11622/smedj.2014111
Drug-induced immune haemolytic anaemia caused by levofloxacin
Sukhal S, Gupta S
Correspondence: Dr Shashvat Sukhal, ssukhal@cookcountyhhs.org
ABSTRACT
Drug-induced immune haemolytic anaemia (DIIHA) is extremely rare. We herein report a case of life-threatening DIIHA due to levofloxacin. This is the second case reported in the literature. A 51-year-old woman presented with complaints of fatigue after 4–5 days of levofloxacin therapy for a lung infection. At presentation, she was found to have haemolysis with a positive Coombs test and IgG autoantibodies. Levofloxacin was identified as the probable culprit, using the Naranjo adverse drug reaction probability scale. Upon discontinuation of the drug and initiation of steroids, the patient’s haematological parameters stabilised. Diagnosis of DIIHA is made through a history of intake of levofloxacin, clinical and laboratory features of haemolysis and a positive Coombs test. An autoantibody screen is most commonly positive for warm antibodies (IgG type). It is essential for clinicians to recognise this rare complication caused by a commonly prescribed medication, discontinue the offending drug and initiate treatment.
Keywords: drug-induced immune haemolytic anaemia, haemolytic anaemia, levofloxacin
Singapore Med J 2014; 55(8): e136-e138; http://dx.doi.org/10.11622/smedj.2014111
REFERENCES
1. Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2009:73-9. http://dx.doi.org/10.1182/asheducation-2009.1.73 |
|
2. Oh YR, Carr-Lopez SM, Probasco JM, Crawley PG. Levofloxacin-induced autoimmune hemolytic anemia. Ann Pharmacother 2003; 37:1010-3. http://dx.doi.org/10.1345/aph.1C525 |
|
3. Naranjo CA, Busto U, Sellers EM, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239?45. http://dx.doi.org/10.1038/clpt.1981.154 |
|
4. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol 2002; 69:258-71. http://dx.doi.org/10.1002/ajh.10062 |
|
5. Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf 2012; 11:635-42. http://dx.doi.org/10.1517/14740338.2012.678832 |
|
6. Broadberry RE, Farren TW, Bevin SV, et al. Tazobactam-induced haemolytic anaemia, possible cause by non-immunological adsorption of IgG onto patient's red cells. Transfus Med 2004; 14:53-7. http://dx.doi.org/10.1111/j.0958-7578.2004.00481.x |
|
7. Petz LD. Treatment of autoimmune hemolytic anemias. Curr Opin Hematol 2001; 8:411-6. http://dx.doi.org/10.1097/00062752-200111000-00016 |
|
8. Winklestein A, Kiss JE. Immunohematologic disorders. JAMA 1997; 278:1982-92. http://dx.doi.org/10.1001/jama.1997.03550220188024 |
|
9. Campi P, Pichler WJ. Quinolone hypersensitivity. Curr Opin Allergy Clin Immunol 2003; 3:275-81. http://dx.doi.org/10.1097/00130832-200308000-00007 |